Frameworks for Decision-Making & Lessons Learned from “Failing Fast”

by Biotech Newsroom


By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC

Drug discovery and development is a long, and often fraught, journey – it typically takes more than a decade to progress from idea to approved drug, and less than 10% of drugs that enter the clinic succeed in achieving commercialization. Creating new drugs for patients is certainly not for the faint of heart. Behind every story of a drug approved there are countless tales of challenges, whether it was early technology that failed to scale, early compounds that proved toxic in IND-enabling studies, lack of clinical efficacy that wasn’t…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC